z-logo
open-access-imgOpen Access
Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial
Author(s) -
J.B. Buse,
A.L. Carlson,
M. Komatsu,
O. Mosenzon,
L. Rose,
B. Liang,
K. Buchholtz,
H. Horio,
T. Kadowaki
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/bbtv-d113
Subject(s) - insulin aspart , insulin degludec , medicine , double blind , insulin , type 2 diabetes , diabetes mellitus , endocrinology , randomized controlled trial , insulin glargine , alternative medicine , placebo , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom